Clinical Trials
- Diabetes
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)
- Ages3 years and older
- GenderBoth
- Children's Health, Diabetes, Endocrine System
Pathway to Prevention
- Ages1 year - 45 years
- GenderBoth
- Diabetes
TrialNet TOPPLE Study for People with Type 1 Diabetes
- Ages18 years - 45 years
- GenderBoth